Oct 2026· Journal of Surgical Research· Vol 328, pp.
150-158
· 0 citations· 27 references
Medicine
TL;DR
PNI-positive PDAC demonstrate enrichment of EMT-related transcriptional programs with concordant microenvironmental and gene-level support, which contrasts with EMT enrichment, which was supported by concordant biological features.
Abstract
INTRODUCTION
Perineural invasion (PNI) is a high-risk feature of pancreatic ductal adenocarcinoma (PDAC) and is associated with aggressive behavior and poor outcomes. The biological programs associated with PNI in PDAC remain incompletely characterized.
Methods
PDAC patients in The Cancer Genome Atlas were stratified by PNI status. Gene set enrichment analysis using Hallmark gene sets was performed to characterize transcriptomic differences between PNI-positive and PNI-negative tumors. Established immune, proliferative, and genomic annotations curated from prior The Cancer Genome Atlas analyses were used for downstream comparisons.
Results
A total of 101 PNI-positive and 26 PNI-negative tumors were identified. PNI was associated with higher grade (P < 0.05). Gene set enrichment analysis demonstrated enrichment of multiple gene sets in PNI-positive tumors, including pathways related to cell proliferation (G2M checkpoint, mTORC1 signaling, E2F targets, MYC targets, and mitotic spindle), immune signaling (tumor necrosis factor-α signaling via NF-κB, interferon-α, and γ responses), and epithelial-mesenchymal transition (EMT). Yet, no differences were observed in measures of tumor proliferation, aggressiveness, mutational burden, immune response, or immune cell infiltration within the tumor microenvironment. In contrast, EMT enrichment was supported by concordant biological features, including increased infiltration of mesenchymal cells and elevated expression of EMT-associated genes in PNI-positive tumors.
Conclusions
PNI-positive PDAC demonstrate enrichment of EMT-related transcriptional programs with concordant microenvironmental and gene-level support.
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, and approximately 15% of cases arise from intraductal papillary mucinous neoplasms (IPMNs). These precursor lesions can progress to invasive cancer through the accumulation of molecular alterations. To identify pathways associated with this...
I. Grassi, Elisabetta Di Nicola, Erica Candela et al.· International Journal of Mol...· 0 citations
This study identifies TRIM29 as a machine learning-prioritized diagnostic biomarker and functional regulator of PDAC progression and immune remodeling, suggesting its potential value for biomarker-guided risk assessment and therapeutic exploration in PDAC.
Shuai-Wu Luo, Yong-Hao Xu, Wen-Jun Liao et al.· Pancreatology : official jou...· 0 citations
Perineural invasion (PNI) is an aggressive biological feature of colorectal cancer (CRC) driven by active crosstalk between tumor cells, Schwann cells, and the neural microenvironment. Although PNI is associated with recurrence, distant metastasis, and chemoresistance, its pathologic diagnosis is constrained by sam...
Shu-Zhe Yang, Zhong-Yuan Bai, Ya-Nan Li et al.· Frontiers in Oncology· 0 citations
Analysis of invasion status parses composition of the human pancreatic cancer perineural niche revealed that invaded nerve neighborhoods harbor cancer cells of the classical subtype, together with myofibroblastic cancer-associated fibroblasts (CAFs) and lipid-associated macrophages.
Zainab Hussain, Dig Vijay Kumar Yarlagadda, Qian-Zi Li et al.· Cancer Research· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) with anaplastic features is a rare and highly aggressive subtype with an extremely poor prognosis. However, the molecular mechanisms underlying anaplastic transformation remain poorly understood. To characterize the anaplastic transformation molecular landscape, we analyzed genom...
Akimasa Hayashi, Shota Sasagawa, Takahiro Shibayama et al.· Journal of Pathology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.